Integration of DNA Copy Number Alterations and Prognostic Gene Expression Signatures in Breast Cancer Patients
Hugo M. Horlings, Marc J. van de Vijver(The Netherlands Cancer Institute), Carmen Lai(Delft University of Technology), Erik van Beers(Amsterdam UMC Location University of Amsterdam), Christiaan Klijn(Genmab (United States)), Dimitry S.A. Nuyten(The Netherlands Cancer Institute), Marcel Reinders(Leiden University), Simon A. Joosse(Universität Hamburg), Hans Halfwerk(Amsterdam UMC Location University of Amsterdam), Lodewyk F.A. Wessels(The Netherlands Cancer Institute), Petra M. Nederlof(The Netherlands Cancer Institute), Petra Kristel(The Netherlands Cancer Institute)
Cited by 69
Related Papers
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
|New England Journal of Medicine|2002|6.5k
The consensus molecular subtypes of colorectal cancer
|Nature Medicine|2015|5.3k
A Landscape of Pharmacogenomic Interactions in Cancer
|Cell|2016|2.3k
AACR Project GENIE: Powering Precision Medicine through an International Consortium
|Cancer Discovery|2017|2k